Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19

被引：87

作者：

Sharun, Khan ^{[1
]}

Dhama, Kuldeep ^{[2
]}

Patel, Shailesh Kumar ^{[2
]}

Pathak, Mamta ^{[2
]}

Tiwari, Ruchi ^{[3
]}

Singh, Bhoj Raj ^{[4
]}

Sah, Ranjit ^{[5
]}

Bonilla-Aldana, D. Katterine ^{[6
,7
]}

Rodriguez-Morales, Alfonso J. ^{[7
,8
]}

Leblebicioglu, Hakan ^{[9
]}

机构：

[1] ICAR Indian Vet Res Inst, Div Surg, Bareilly 243122, Uttar Pradesh, India

[2] ICAR Indian Vet Res Inst, Div Pathol, Bareilly 243122, Uttar Pradesh, India

[3] UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vig, Dept Vet Microbiol & Immunol, Coll Vet Sci, Mathura 281001, India

[4] ICAR Indian Vet Res Inst, Div Epidemiol, Bareilly 243122, Uttar Pradesh, India

[5] Tribhuvan Univ Teaching Hosp, Inst Med, Dept Microbiol, Kathmandu, Nepal

[6] Fdn Univ Autonoma Amer, Semillero Zoonosis, Grp Invest BIOECOS, Sede Pereira, Pereira, Risaralda, Colombia

[7] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Colombia

[8] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Risaralda, Colombia

[9] Samsun Liv Hosp, Dept Infect Dis, Samsun, Turkey

来源：

ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS | 2020年 / 19卷 / 01期

关键词：

COVID-19; 2019-nCoV; SARS-CoV-2; Coronavirus; Therapeutics; Ivermectin; NUCLEAR IMPORT; WONDER DRUG; VIRUS; REPLICATION; INHIBITORS;

D O I：

10.1186/s12941-020-00368-w

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页数：5

共 25 条

[1]

Azeem S, 2015, PAK J PHARM SCI, V28, P597

[2] A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection [J].

Barrows, Nicholas J. ;

Campos, Rafael K. ;

Powell, Steven T. ;

Prasanth, K. Reddisiva ;

Schott-Lerner, Geraldine ;

Soto-Acosta, Ruben ;

Galarza-Munoz, Gaddiel ;

McGrath, Erica L. ;

Urrabaz-Garza, Rheanna ;

Gao, Junling ;

Wu, Ping ;

Menon, Ramkumar ;

Saade, George ;

Fernandez-Salas, Ildefonso ;

Rossi, Shannan L. ;

Vasilakis, Nikos ;

Routh, Andrew ;

Bradrick, Shelton S. ;

Garcia-Blanco, Mariano A. .

CELL HOST & MICROBE, 2016, 20 (02) :259-270

[3] The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro [J].

Caly, Leon ;

Druce, Julian D. ;

Catton, Mike G. ;

Jans, David A. ;

Wagstaff, Kylie M. .

ANTIVIRAL RESEARCH, 2020, 178

[4] IVERMECTIN - A REVIEW OF EFFICACY AND SAFETY [J].

CAMPBELL, WC ;

BENZ, GW .

JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1984, 7 (01) :1-16

[5] Liposomal Systems as Nanocarriers for the Antiviral Agent Ivermectin [J].

Croci, Romina ;

Bottaro, Elisabetta ;

Chan, Kitti Wing Ki ;

Watanabe, Satoru ;

Pezzullo, Margherita ;

Mastrangelo, Eloise ;

Nastruzzi, Claudio .

INTERNATIONAL JOURNAL OF BIOMATERIALS, 2016, 2016

[6] Ivermectin: enigmatic multifaceted 'wonder' drug continues to surprise and exceed expectations [J].

Crump, Andy .

JOURNAL OF ANTIBIOTICS, 2017, 70 (05) :495-505

[7] Ivermectin, 'Wonder drug' from Japan: the human use perspective [J].

Crump, Andy ;

Omura, Satoshi .

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES, 2011, 87 (02) :13-28

[8] Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import [J].

Goetz, Veronika ;

Magar, Linda ;

Dornfeld, Dominik ;

Giese, Sebastian ;

Pohlmann, Anne ;

Hoeper, Dirk ;

Kong, Byung-Whi ;

Jans, David A. ;

Beer, Martin ;

Haller, Otto ;

Schwemmle, Martin .

SCIENTIFIC REPORTS, 2016, 6

[9] Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system [J].

Ketkar, Harshada ;

Yang, Long ;

Wormser, Gary P. ;

Wang, Penghua .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (01) :38-40

[10] Ivermectin inhibits porcine reproductive and respiratory syndrome virus in cultured porcine alveolar macrophages [J].

Lee, Yoo Jin ;

Lee, Changhee .

ARCHIVES OF VIROLOGY, 2016, 161 (02) :257-268

← 1 2 3 →